The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Bipolar disorder (BD) is a mood disorder with subtypes characterized by episodes of mania, hypomania, and/or depression. BD is associated with substantial economic burden, and the bipolar I disorder (BD-I) subtype is associated with high medical costs. This review further evaluated the economic burden of BD and BD-I in the United States (US), describing health-care resource utilization (HCRU) and sources of direct medical and indirect costs. Data were obtained from systematic searches of MEDLINE ® , EMBASE ® , and National Health Service Economic Evaluation Database. Citations were screened to identify primary research studies (published 2008– 2018) on the economic burden of BD/BD-I or its treatment in real-world settings. Reported costs were converted to 2018 US dollars. Of identified abstracts (N=4111), 56 studies were included. The estimated total annual national economic burden of BD/BD-I was more than $195 billion, with approximately 25% attributed to direct medical costs. Individuals with BD/BD-I used health-care services more frequently and had higher direct medical costs than matched individuals without the disease. Drivers of higher direct costs included frequent psychiatric interventions, presence of comorbid medical/psychiatric conditions, and both suboptimal medication adherence and clinical management. Indirect costs (eg, unemployment, lost work productivity for patients/caregivers) accounted for 72– 80% of the national economic burden of BD/BD-I. Different definitions for study populations and cost categories limited comparisons of economic outcomes. This review builds on existing literature describing the economic burden of BD and confirmed cost drivers of BD/BD-I. Improved clinical management of BD/BD-I and associated comorbidities, together with better medication adherence, may reduce health-care costs and improve patient outcomes. Keywords: cost of illness, health care costs, indirect costs, mania, mood disorder, resource utilization
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528
Estimating the true global burden of mental illness
Vigo, D., Thornicroft, G., & Atun, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00505-2 · Cited by 2,494
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Research works printed but not linked: 7
- Rhee, 2020, Am J Psychiatry, appiajp202019091000
- Baldessarini, 2008, Psychiatr Serv, 59, 1175, 10.1176/ps.2008.59.10.1175 · DOI · Paper page
- Pelletier, 2013, Am J Pharm Benefits, 5, e73
- Chatterton, 2008, P T, 33, 15
- Wright, 2016, J Manag Care Spec Pharm, 22, 1330
- Stensland, 2010, J Ment Health Policy Econ, 13, 87
- Seabury, 2014, Am J Manag Care, 20, e52
Cited by
Items 101–172 of 172
Epidemiology of Bipolar Disorder
Kessing, L. V. (2025) · Springer eBooks · doi:10.1007/978-3-032-01297-5_2 · Cited by 1
Awasthi, S., Huang, D., Lynum, K. S. B., & Nag, S. S. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2026.32.1.66 · Cited by 1
Kumar, D., Awan, A. I., Khan, M. T., Shujaat, T., Kumar, S., & Usman, M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121389 · Cited by 1
Levchuk, L. A., Викторовна, М. Е., Epimakhova, E. V., Рощина, О. В., Васильева, С. Н., Бойко, А. С., Simutkin, G. G., Bokhan, N. A., & Ivanova, S. А. (2026) · Psikhiatriya · doi:10.30629/2618-6667-2026-24-2-60-72 · Cited by 1
Muhammad, Y. A. (2026) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2026.1775109 · Cited by 1
“…anxiety disorders, substance use disorders, metabolic syndrome, and cardiovascular disease - pointing toward systemic biological dysregulation rather than a condition limited to the central nervous system (Bessonova et al., 2020; Wang et al., 2022a,b; Sinha et al., 2018; Yamagata et al., 2017).”
Paribello, P., Pinna, F., Carpiniello, B., & Manchia, M. (2022) · Psychiatry International · doi:10.3390/psychiatryint3010009 · Cited by 1
“Despite the high costs in terms of individual suffering and socioeconomic impact [7,8], there are still numerous unmet needs in risk stratification, diagnostic accuracy, and treatment selection, all key components of precision psychiatry [9,10].”
BackgroundBayes, A. J. (2023) · Bipolar Disorders · doi:10.1111/bdi.13354 · Cited by 1
Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey
Adachi, N., Kubota, Y., Goto, E., Watanabe, K., Yoshimura, R., Tsuboi, T., Yasui‐Furukori, N., Kato, M., Hongo, S., Azekawa, T., et al. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2224047 · Cited by 1
Gannon, J. M., Sanchez, M., Lines, K., Cairns, K., Reardon, C., Chengappa, K. N. R., & Calkin, C. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001818 · Cited by 2
Self-assembled nanomaterials enable extended lithium release
Zamani, M., Monir, K., & Furst, A. L. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00901d · Cited by 1
Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany
Reif, A., Baune, B. T., Deckert, J., Juckel, G., Kittel‐Schneider, S., Kircher, T. T. J., Kornhuber, J., Rupprecht, R., & Bauer, M. (2021) · Pharmacopsychiatry · doi:10.1055/a-1697-5854
An Overview of Sleep and Circadian Rhythms in Bipolar DisorderPreprint
Bisdounis, L., McGowan, N. M., & Saunders, K. (2022) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/9cy4n
Economic burden of bipoolar disorders in USA
(2020) · PharmacoEconomics & Outcomes News · doi:10.1007/s40274-020-7130-9
Bipolar disorder(BPD):epidemiological characteristics, current situation and treatment
Wang, Z. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v14i.1603
“1 billion dollar and 88,443 dollars per person, showing a great burden in national fiscal expenditure [3].”
BackgroundWaters, H. C., Touya, M., Wee, S. N., Ng, M. S. W., Thadani, S., Surendran, S., Rentería, M. E., Rush, A. J., Patel, R., Sarkar, J., et al. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2148461
Comorbidity in bipolar disorder, volume II
(2023) · Frontiers research topics · doi:10.3389/978-2-83251-906-6
Hoffmann, M. W., Cywes, R., Childers, A. M., Kossoff, M. M., Kossoff, E. H., Perlmutter, D., Phillips, M. C. L., Edes, G., Berger, A., Stanton, A. A., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821617-0.00006-1
Knowles, E. A., Schneier, L. G., Yang, L., & Meter, A. V. (2023) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-023-09610-w · Cited by 1
“…medical/psychiatric conditions and suboptimal medication adherence and clinical management, most of the economic burden of BD can be attributed to indirect costs, such as unemployment and lost work productivity, which account for 72–80% of the national economic burden (Bessonova et al., 2020 ).”
Biomedical and public health studies on susceptibility to post-traumatic stress disorder
Jowf, G. I. A. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230906ga
An Update on the Treatment of Manic and Hypomanic States
Jauhar, S., & Wong, S. L. A. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108973922.021
The Socioeconomic Costs of Mood Disorders
McCrone, P. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108973922.007
Bipolar Disorder in the Working Population: The Occupational Health Nurse’s Role
Armijo, J., & Rosemberg, M.-A. S. (2024) · Workplace Health & Safety · doi:10.1177/21650799241261081
Epidemiology of Mental Disorders in Adult Women
Carpenter, R., Carpenter, M., & Cuffe, S. P. (2024) · Springer eBooks · doi:10.1007/978-3-031-58293-6_3
Doane, M. J., Jauregui, A., & Panchmatia, H. R. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02953-3
“Evidence suggests that BD-I is associated with increased healthcare resource utilization (HCRU), reduced health-related quality of life (HRQoL), and higher medical costs [3, 4, 11].”
BackgroundResultInfluentialSelf-citationПриверженность пациентов к лекарственной терапии при биполярном аффективном расстройстве
Васильева, С. Н., Simutkin, G. G., Schastnyy, E. D., Лебедева, Е. В., Surovtseva, A. K., Смирнова, Н. С., & Didenko, E. V. (2024) · Сибирский вестник психиатрии и наркологии · doi:10.26617/1810-3111-2024-2(123)-41-48
Conger, C., & Cottler, L. B. (2024) · Discover Mental Health · doi:10.1007/s44192-024-00091-4
Laha, P., Basavaraju, R., Parameshwaran, S., Dinakaran, D., Malo, P. K., Bhaskarapillai, B., & Kesavan, M. (2024) · Journal of Psychiatry Spectrum · doi:10.4103/jopsys.jopsys_36_24
Polymorphisms and Bipolar Disorder
Nikpour, P., & Smedler, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_21-1
Bipolar Disorder: Screening in the Primary Care Setting to Improve Referrals for Care
Bursnall, P., & Johnson, L. L. (2025) · Clinical Journal for Nurse Practitioners in Women s Health · doi:10.1891/cjnpwh-2519
Pain in women with and without bipolar spectrum disorder
Stuart, A. L., Berk, M., Pasco, J. A., Mohebbi, M., Quirk, S. E., & Williams, L. J. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1501382
Electroconvulsive therapy and autobiographical memory
Scott, R. J., Prowacki, S., & Purushothaman, S. (2025) · Psychiatry Psychology and Law · doi:10.1080/13218719.2025.2486082
Razavilar, N., Chan, B., Chokka, P. R., van-Katwyk, S., Liu, Y. S., & Unsal, A. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119837
Comorbidity with other medical conditions
Vázquez, G. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33580-8.00017-9
Treatment-resistant bipolar depression
Díaz, A. P., Fernandes, B. S., Quevedo, J., Sanches, M., & Soares, J. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00026-8
Polymorphisms and Bipolar Disorder
Nikpour, P., & Smedler, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_21
Ketamine for depression and other psychiatric diseases
Roth, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29930-8.00005-9
Protein - Biomarker zur Unterscheidung zwischen unipolarer und bipolarer Depression
Kussberger, J. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-37110
The role of sleep and circadian rhythms in bipolar disorder
Bisdounis, L. (2024) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-kovx7qqww
Benáček, J., Martin-Key, N. A., Spadaro, B., Tomasik, J., & Bahn, S. (2022) · Figshare · doi:10.6084/m9.figshare.20047227
FAKINLEDE, Y. (2024) · ScholarWorks (Walden University)
Suicidal Ideation and Bipolar Disorder Risk and Mood Severity in Emerging Adults
Hargrove, R. (2022) · CU Scholar (University of Colorado Boulder)
Training Nurse Practitioners and Providers in Primary Care to Screen for Bipolar Disorder
IWEBO, J. N. (2024) · ScholarWorks (Walden University)
Staff Education for Nurses and Providers on Rapid Mood Screener
ogunleye, L. A. (2023) · ScholarWorks (Walden University)
The Association of Lower Medication Adherence and Increased Medical Spending
Fuchs, R. A. (2022) · DigitalCommons@UNMC
The Impact of the CACNA1C Risk Allele on Cognitive Functioning in Euthymic Type I Bipolar Disorder
Gazor, N. (2023) · MacSphere (McMaster University) · doi:10.71548/24154
Network-specific Cerebellar-Cortical Connectivity Alterations in Bipolar Disorder and Schizophrenia
Kim, M. (2021) · NORA - Norwegian Open Research Archives
Serravalle, L. (2023) · Spectrum Research Repository (Concordia University)
Guimarães, A. L., Fernandes, E., Salgado, I., da Silva, R. D. A., Nardi, A. E., Cheniaux, E., & Mograbi, D. C. (2025) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2025.100174
Abu-Hijleh, F. (2024) · MacSphere (McMaster University) · doi:10.71548/9818
Kunovszki, P., Bálint, L., Rihmer, Z., Kapitány, B., Leleszi, A., Lazáry, J., Fehér, L., Horváth, A., Ezsi, R., Kapitány‐Fövény, M., et al. (2026) · Orvosi Hetilap · doi:10.1556/650.2026.33472
Redefining Acute Psychiatric Care: Strategies for Improved Inpatient Experiences
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7408-9
Affective Dynamics and Digital Mental Health Tools in Bipolar Disorder
Lim, M. (2025) · UCL Discovery (University College London)
Influential Factors on the Family Functioning of Patients With Bipolar Disorder: A Qualitative Study
Yaghmaei, S., Babamohamadi, H., Shamsaei, F., & Ghods, A. A. (2026) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.70117
Detecting Mood State Differences Through Digital Behavioural Monitoring in Bipolar Disorder
Zhang, J. H. (2024) · TSpace (University of Toronto)
Sex-specific Differences in Heart Rate Variability in Bipolar Disorder
Yang, D. (2023) · TSpace (University of Toronto)
Yang, H.-H., Han, K., Kang, Y., Shin, D., Tae, W., Han, M.-R., & Ham, B. (2026) · Psychological Medicine · doi:10.1017/s003329172610347x
“The overall prevalence of BD is approximately 1%, with a heritability rate of approximately 60% (Bessonova et al., 2020; Merikangas et al., 2011; Smoller & Finn, 2003; Song et al., 2018).”
Khafif, T. C., Belizário, G. O., Lafer, B., & Gomes, B. C. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1697134
Yalın, N., & Yildiz, A. (2026) · Neuropsychobiology · doi:10.1159/000551232
“The associated decline in functioning ultimately reduces the quality of life [14] and significantly increases the economic impact of the disorder via indirect costs, accounting for up to 80% of the total financial burden [15].”
Inder, M., Crowe, M., & Porter, R. J. (2026) · Community Mental Health Journal · doi:10.1007/s10597-026-01613-w
“…with BD including direct healthcare costs`, particularly inpatient care`, and indirect costs such as unemployment and caregiver productivity loss (Bessonova et al., 2020; Young et al., 2011 ) weighted up with the finan - cial positive benefits of more effective treatments for those with BD…”
Mellick, W. H., Tolliver, B. K., Anton, R. F., & Prisciandaro, J. J. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02418-x
“…alcohol use disorder (AUD), leading to more severe manic and depressive symptoms, more frequent mood episodes, treatment resistance, and increased suicide risk, disproportionately contributing to the $195 billion estimated total annual national economic burden associated with BD [1, 2].”
The effect of lithium on neurosteroids in SH-SY5Y cells
Nainkwi, F. C., Gözgöz, H., San, T., Arayıcı, M., & Doruk, Ö. G. (2026) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2025-0532
“BD is a disorder characterized by depression and manic episodes, and the place of lithium in treatment of it is indispensable and lithium still maintains its place as the fi rst line treatment option in acute mania, depressive episodes, and maintenance treatment [4].”
Ozkan, O., Khanna, A., Rodriguez, L. R., Rapp, E., Pajiyar, A., Suthar, H. J., & Parikh, P. (2026) · International Journal of Advanced Research · doi:10.21474/ijar01/23462
Association Between Expressed Emotion and Relapse of Bipolar Disorder: A Systematic Review
Tong, S. Y., Dye, M. C. H., Yue, A. H. T., Li, Y., & Ma, C. F. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap47961
“Moreover, the exploration of this area is particularly important, given the substantial personal, social, economic, and healthcare burdens associated with individuals and the care of individuals with BD and relapse [27–30].”
Schandorff, J. M., Damgaard, V., Johansen, A., Macoveanu, J., Cramer, K., Madsen, A. B. F., Orum, B. E. R., Bruun, C. F., Meyer, M., Plavén‐Sigray, P., et al. (2026) · medRxiv · doi:10.64898/2026.07.10.26357722
Henneberg, P. M., Beesdo‐Baum, K., Marxen, M., Joshi, G., Hilbert, K., Muehlhan, M., Huth, F., Mikoláš, P., & Mennigen, E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04269-y
“In addition to substantial personal burden, affective disorders impose major societal and economic costs driven by early onset and often recurrent or chronic courses [6, 7].”
Imaging features of affective and non-affective psychosis
Delvecchio, G., Pigoni, A., Videtta, G., Colli, C., Squarcina, L., Bottaro, F., Enrico, P., Bellani, M., Maggioni, E., & Brambilla, P. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122326
Gardea‐Resendez, M. (2026) · El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León)
McIntyre, R. S., Parikh, M., Zanardo, E., Laliberté, F., Nguyen, H., Christopher, E. J., Aronin, L. C., Zhang, K., Ma, S., & Ta, J. T. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03654-9
Chen, M., Ding, N., Qiu, X., Li, L., Guo, Y., Wang, R., Mo, X., Zou, T., Yu, S., Li, X., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71179
“For example, BD patients cost approximately 5.8 billion euros per year in Germany [5], and the total cost for BD patients in the United States over 10 years has been estimated at 204 billion dollars [6].”
InfluentialJain, R., Panchmatia, H. R., Hughes, A. G., Doane, M. J., Oyedeji, H. E., & Cutler, A. J. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03807-w
Self-citationPalacios-Ariza, M. A., Morales-Mendoza, E., Murcia, J., Arias-Duarte, R., Lara-Castellanos, G., Cely-Jiménez, A., Rincón-Acuña, J. C., Araúzo-Bravo, M. J., & McDouall, J. (2023) · doi:10.3389/fpsyt.2023.1266548.s001
Metadata
- Authors
- Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M.
- Affiliations
- Alkermes (United States) (US)
- Worldwide Clinical Trials (United States) (US)
- University of New Mexico (US)
- Corresponding author
- Bessonova, Leona
- Venue
- ClinicoEconomics and Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2020-09
- Volume
- Volume 12
- Pages
- 481-497
- ISSN
- 1178-6981 (ISSN-L)
- PMC
- PMC7489939
- OpenAlex
- W3083267042
- Semantic Scholar
- 4b10052566feb7dd1f10943dfd9f816c3f7583ab
- Cited by
- 147
- References
- 78
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 29 · 2023: 29 · 2022: 28 · 2021: 12 · 2020: 1
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- ClinicoEconomics and Outcomes Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- bipolar disorder, bipolar I disorder, economic burden, healthcare resource utilization, direct medical costs, indirect costs, productivity loss, medication adherence, comorbidities, mania, mood disorders, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.